CytoMed Therapeutics Ltd (GDTC) Live Share Price, Invest From India

CytoMed Therapeutics Ltd Stock Performance

as on March 11, 2026 at 6:58 am IST

Day's Low
Day's High
$1.01
Day's Price Range
$1.04
$1.02
0.98%
Downside
1.96%
Upside
52 Week's Low
52 Week's High
$0.73
52-Week Price Range
$3.68
$1.02
28.61%
Downside
260.78%
Upside

CytoMed Therapeutics Ltd share price movements today

Previous Close: $1.06
Open: $1.01
Volume: 75.0K
Day's Low - High: $1.01 - $1.04
52 Week Low - High: $0.73 - $3.68

CytoMed Therapeutics Ltd Historical Returns

1 Month Return: -0.93 %
3 Month Return: -31.93 %
1 Year Return: -57.6 %
3 Year Return: 0 %
5 Year Return: 0 %

CytoMed Therapeutics Ltd Stock Fundamentals & Key Indicators

Check CytoMed Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.5M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-3.2M

Revenue (TTM)

729.9K

Profit Margin

0.00%

Return On Equity TTM

-42.33%

CytoMed Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CytoMed Therapeutics Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
CytoMed Therapeutics Ltd	BUY	$22.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.5B	140.27%	137.03	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$116.0B	115.07%	29.85	32.94%
Beone Medicines Ltd	NA	$33.3B	NA	590.43	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.3B	67.03%	18.31	31.41%

Stock Returns calculator for CytoMed Therapeutics Ltd Stock including INR - Dollar returns

The CytoMed Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

CytoMed Therapeutics Ltd investment value today

Current value as on today

₹45,992

Returns

₹54,008

(-54.01%)

Returns from CytoMed Therapeutics Ltd Stock

₹59,200 (-59.2%)

Dollar Returns*

₹5,192 (+5.19%)

Analyst Recommendation on CytoMed Therapeutics Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for CytoMed Therapeutics Ltd. Average target price of $5

CytoMed Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on CytoMed Therapeutics Ltd.

What analysts predicted

79.6%UPSIDE

Target Price

Current Price

$1.02

Analyzed by

7 Analysts

Target

$5.00

CytoMed Therapeutics Ltd target price $5, a slight upside of 79.6% compared to current price of $1.02. According to 7 analysts rating.

CytoMed Therapeutics Ltd Stock’s Investor Sentiment and Interest

Search interest for CytoMed Therapeutics Ltd Stock has increased by 81% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 9, 2026 to March 11, 2026

Change:81% versus previous 30 day period

CytoMed Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	0	-1	0	0	-1	0	0	0
EBITDA	0	-1	0	0	0	0	0	0
Interest Expense	0	0	-	0	0	-	0	0
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	0	-1	0	0	0	0	0	0
Income Tax Expense	0	0	0	0	0	-	-	-
Net Income	0	-1	0	0	0	0	0	0
Net Profit Margin	-759.30%	-1536.81%	-883.54%	-485.50%	-977.37%	-511.59%	-834.68%	-834.68%

CytoMed Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-1	-1	-1	-3	-2
EBITDA	0	-1	-1	-2	-1
Interest Expense	0	0	0	0	0
Depreciation	0	0	0	0	0
Income Before Tax	-1	-1	-2	-3	-1
Income Tax Expense	0	0	0	0	-
Net Income	-1	-1	-1	-2	-1
Net Profit Margin	-3266.07%	-1822.31%	-839.94%	-1077.85%	-3621.15%

CytoMed Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Jun 2025
Net Income	0	0	0	-1	0	0	0
Operating Cash Flow	0	-1	0	-1	0	0	-1
Investing Cash Flow	-2	0	0	-	-1	1	0
Financing Cash Flow	4	8	0	0	0	0	0
Change in Cash	-1	3	-3	0	-2	-	-1

CytoMed Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-1	-2	-3	-1
Operating Cash Flow	0	-1	-1	-2	-1
Investing Cash Flow	0	0	0	-2	0
Financing Cash Flow	1	3	0	8	0
Change in Cash	0	1	0	3	-1

Insights on CytoMed Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 100.04K → 105.70K (in $), with an average increase of 5.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.8% return, outperforming this stock by 96.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -555.67K → -882.3K (in $), with an average decrease of 28.0% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 months, GDTC stock has moved down by -31.9%

About CytoMed Therapeutics Ltd

incorporated in 2018, cytomed therapeutics is a spin-off from singapore’s agency for science, technology and research ( a*star) and focuses on translating its patented technologies into gamma delta (γδ) t cell- and natural killer (nk) cell-based “off-the-shelf” immunotherapeutics for a wide range of cancers. we also engage in generating induced pluripotent stem cells (ipscs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.

Organisation	CytoMed Therapeutics Ltd
Headquarters	1 Commonwealth Lane, Singapore, Singapore, 149544
CEO	Mr. Chee Kong Choo
E-voting on shares	Click here to vote

Key Management of CytoMed Therapeutics Ltd

Name	Title
Mr. Chee Kong Choo	Executive Chairman
Dr. Jieming Zeng M.D., Ph.D.	Chief Scientific & Medical Officer and Director
Ms. Yvonne Goh	Chief Financial Officer
Dr. Tien Wee Luk M.D.	Chief Clinical Officer
Ms. Yoong Ying Tan	Chief Corporate Officer

FAQs

What is CytoMed Therapeutics Ltd share price today?

CytoMed Therapeutics Ltd share price today is $1.02 as on March 11, 2026 at 1:28 am IST. CytoMed Therapeutics Ltd share today touched a day high of $1.04 and a low of $1.01.

What is the 52 week high and 52 week low for CytoMed Therapeutics Ltd share?

CytoMed Therapeutics Ltd share touched a 52 week high of $3.68 on October 22, 2025 and a 52 week low of $0.73 on January 27, 2026. CytoMed Therapeutics Ltd stock price today i.e. March 11, 2026 at 1:28 am IST is trending at $1.02,which is 72.28% down from its 52 week high and 40.07% up from its 52 week low.

What is CytoMed Therapeutics Ltd's market capitalisation today?

CytoMed Therapeutics Ltd market capitalisation is $0.00T as on March 11, 2026 at 1:28 am IST.

How to invest in CytoMed Therapeutics Ltd Stock (GDTC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for CytoMed Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CytoMed Therapeutics Ltd Shares that will get you 1.4706 shares as per CytoMed Therapeutics Ltd share price of $1.02 per share as on March 11, 2026 at 1:28 am IST.

What is the minimum amount required to buy CytoMed Therapeutics Ltd Stock (GDTC) from India?

Indian investors can start investing in CytoMed Therapeutics Ltd (GDTC) shares with as little as ₹91.833 or $1 (as of March 11, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in CytoMed Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on March 11, 2026 at 1:41 am IST). Based on CytoMed Therapeutics Ltd share’s latest price of $1.02 as on March 11, 2026 at 1:28 am IST, you will get 9.8039 shares of CytoMed Therapeutics Ltd. Learn more about fractional shares .